AI assistant
CSL Ltd. — Board/Management Information 2006
Aug 31, 2006
17854_rns_2006-08-31_f99c66f5-2d79-4544-ada7-489ff9dea028.pdf
Board/Management Information
Open in viewerOpens in your device viewer
CSL Limited 45 Poplar Road Parkville Victoría 3052 Australia
1 +613 9389 1911 F +613 9389 1434 www.csl.com au
1 September 2006
CSL APPOINTS NEW DIRECTOR
CSL today announced that Mr David Simpson has been appointed a Director of the Company effective from 1 September 2006.
Mr Simpson is the non-executive Chairman of Aristocrat Leisure Limited and a Director of Lighthouse Foundation.
For many years Mr Simpson was Finance Director of Tabcorp Holdings Limited and before that Executive General Manager Finance of Southcorp Holdings Ltd.
CSL's Chairman, Mr Peter Wade, said that he was delighted that Mr Simpson had accepted the appointment to the Board, noting that he will replace Elizabeth Alexander as Chairman of the Audit and Risk Management Committee when Miss Alexander takes up her role as Chairman of the Board on Mr Wade's retirement on 30 September 2006.
About CSL Limited
Headquartered in Melbourne, CSL Limited (ASX: CSL) is a global, specialty biopharmaceutical company that develops, manufactures and markets products to treat and prevent serious human medical conditions.
For further information, please contact:
Media contact:
Dr Rachel David Director of Public Affairs Phone: 0401 775 779 Email: [email protected]
Investor contact:
Mark Dehring Director of Investor Relations Phone: +61 3 9389 2818 Email: [email protected]